What is the equity of Ahn-Gook Pharmaceutical Co this year?
Ahn-Gook Pharmaceutical Co has equity of 152.09 B KRW this year.
Ahn-Gook Pharmaceutical Co Equity 2024
Ahn-Gook Pharmaceutical Co Equity
152.09 B KRW
Ticker
001540.KQ
ISIN
KR7001540004
In 2024, Ahn-Gook Pharmaceutical Co's equity was 152.09 B KRW, a -1.75% increase from the 154.8 B KRW equity in the previous year.
Ahn-Gook Pharmaceutical Co Aktienanalyse
What does Ahn-Gook Pharmaceutical Co do?
Ahn-Gook Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Ahn-Gook Pharmaceutical Co's Equity
Ahn-Gook Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Ahn-Gook Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Ahn-Gook Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Ahn-Gook Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Ahn-Gook Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Ahn-Gook Pharmaceutical Co stock
What was the equity of Ahn-Gook Pharmaceutical Co compared to the previous year?
The equity of Ahn-Gook Pharmaceutical Co has increased/decreased by -1.75% decreased compared to the previous year.
What impact does a high equity have on investors of Ahn-Gook Pharmaceutical Co?
A high equity is advantageous for investors of Ahn-Gook Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Ahn-Gook Pharmaceutical Co?
A low equity can be a risk for investors of Ahn-Gook Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Ahn-Gook Pharmaceutical Co affect the company?
An increase in equity of Ahn-Gook Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Ahn-Gook Pharmaceutical Co affect the company?
A reduction in equity of Ahn-Gook Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Ahn-Gook Pharmaceutical Co?
Some factors that can affect the equity of Ahn-Gook Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Ahn-Gook Pharmaceutical Co so important for investors?
The equity of Ahn-Gook Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Ahn-Gook Pharmaceutical Co take to change the equity?
To change equity, Ahn-Gook Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Ahn-Gook Pharmaceutical Co pay?
Over the past 12 months, Ahn-Gook Pharmaceutical Co paid a dividend of 220 KRW . This corresponds to a dividend yield of about 2.99 %. For the coming 12 months, Ahn-Gook Pharmaceutical Co is expected to pay a dividend of 220 KRW.
What is the dividend yield of Ahn-Gook Pharmaceutical Co?
The current dividend yield of Ahn-Gook Pharmaceutical Co is 2.99 %.
When does Ahn-Gook Pharmaceutical Co pay dividends?
Ahn-Gook Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.
How secure is the dividend of Ahn-Gook Pharmaceutical Co?
Ahn-Gook Pharmaceutical Co paid dividends every year for the past 20 years.
What is the dividend of Ahn-Gook Pharmaceutical Co?
For the upcoming 12 months, dividends amounting to 220 KRW are expected. This corresponds to a dividend yield of 2.99 %.
In which sector is Ahn-Gook Pharmaceutical Co located?
Ahn-Gook Pharmaceutical Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ahn-Gook Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ahn-Gook Pharmaceutical Co from 5/1/2024 amounting to 220 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.
When did Ahn-Gook Pharmaceutical Co pay the last dividend?
The last dividend was paid out on 5/1/2024.
What was the dividend of Ahn-Gook Pharmaceutical Co in the year 2023?
In the year 2023, Ahn-Gook Pharmaceutical Co distributed 220 KRW as dividends.
In which currency does Ahn-Gook Pharmaceutical Co pay out the dividend?
The dividends of Ahn-Gook Pharmaceutical Co are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Ahn-Gook Pharmaceutical Co
Our stock analysis for Ahn-Gook Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ahn-Gook Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Ahn-Gook Pharmaceutical Co Revenue
- Ahn-Gook Pharmaceutical Co Net Income
- Ahn-Gook Pharmaceutical Co P/E
- Ahn-Gook Pharmaceutical Co P/S
- Ahn-Gook Pharmaceutical Co EBIT
- Ahn-Gook Pharmaceutical Co Dividend
- Ahn-Gook Pharmaceutical Co Stocks
- Ahn-Gook Pharmaceutical Co Market capitalization
- Ahn-Gook Pharmaceutical Co Debt
- Ahn-Gook Pharmaceutical Co Liabilities
- Ahn-Gook Pharmaceutical Co Equity
- Ahn-Gook Pharmaceutical Co AAQS
- Ahn-Gook Pharmaceutical Co Employees
- Ahn-Gook Pharmaceutical Co ROE
- Ahn-Gook Pharmaceutical Co ROA
- Ahn-Gook Pharmaceutical Co ROCE